Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2021
Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2021
复制标题
DOI：
10.1053/j.gastro.2021.10.017
复制
发表时间：
2022-01-17
期刊：
影响因子：
29.4
通讯作者：
Sandler, Robert S.
中科院分区：
文献类型：
--
作者：
Peery, Anne F.;Crockett, Seth D.;Sandler, Robert S.
背景与目的：胃肠道疾病占相当大的卫生保健使用和支出。我们估计了美国与胃肠道、肝脏和胰腺疾病相关的年度负担、成本和研究资金。方法：我们使用来自国家门诊医疗调查、国家医院门诊医疗调查、全国急诊科样本、全国住院患者样本、儿童住院患者数据库、全国再入院数据库、监测、流行病学和最终结果计划、国家生命统计系统、疾病控制和预防中心流行病学研究的广泛在线数据、MarketScan商业索赔和遭遇数据; MarketScan医疗保险补充数据;器官共享联合网络注册;医疗支出小组调查;和美国国立卫生研究院（NIH）。结果：2018年胃肠道医疗保健支出总额为1196亿美元。每年有超过3，680万人次因胃肠道症状就诊，4，340万人次因主要胃肠道诊断就诊。因主要胃肠道诊断而住院的人数超过380万，其中403，699人再次入院。共进行了2220万次胃肠道内窥镜检查，诊断出284,844例新的胃肠道癌症。胃肠道疾病和癌症造成255，407人死亡。NIH在2020年为胃肠道研究提供了31亿美元（占NIH预算的7.5%）。结论：胃肠道疾病是造成数百万医疗保健遭遇和数十万人死亡的原因，每年在美国花费数十亿美元。为了减轻胃肠道疾病的沉重负担，有必要在额外研究资金的支持下，集中开展临床和公共卫生工作。美国的为此，我们使用多个数据源来生成GI特定的汇总统计数据，包括基于办公室和急诊科（艾德）的访视、成人和儿科住院、再入院和死亡率。我们报告了胃肠道内窥镜检查、癌症和器官移植的统计数据和时间趋势。我们估计了GI特定的医疗保健支出，并总结了美国国立卫生研究院（NIH）对GI研究的资助。
BACKGROUND & AIMS: Gastrointestinal diseases account for considerable health care use and expenditures. We estimated the annual burden, costs, and research funding associated with gastrointestinal, liver, and pancreatic diseases in the United States. METHODS: We generated estimates using data from the National Ambulatory Medical Care Survey; National Hospital Ambulatory Medical Care Survey; Nationwide Emergency Department Sample; National Inpatient Sample; Kids' Inpatient Database; Nationwide Readmissions Database; Surveillance, Epidemiology, and End Results program; National Vital Statistics System; Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research; MarketScan Commercial Claims and Encounters data; MarketScan Medicare Supplemental data; United Network for Organ Sharing registry; Medical Expenditure Panel Survey; and National Institutes of Health (NIH). RESULTS: Gastrointestinal health care expenditures totaled $119.6 billion in 2018. Annually, there were more than 36.8 million ambulatory visits for gastrointestinal symptoms and 43.4 million ambulatory visits with a primary gastrointestinal diagnosis. Hospitalizations for a principal gastrointestinal diagnosis accounted for more than 3.8 million admissions, with 403,699 readmissions. A total of 22.2 million gastrointestinal endoscopies were performed, and 284,844 new gastrointestinal cancers were diagnosed. Gastrointestinal diseases and cancers caused 255,407 deaths. The NIH supported $3.1 billion (7.5% of the NIH budget) for gastrointestinal research in 2020. CONCLUSIONS: Gastrointestinal diseases are responsible for millions of health care encounters and hundreds of thousands of deaths that annually costs billions of dollars in the United States. To reduce the high burden of gastrointestinal diseases, focused clinical and public health efforts, supported by additional research funding, are warranted. the United States. To that end, we used multiple data sources to produce GI-specific summary statistics on office-based and emergency department (ED) visits, adult and pediatric hospitalizations, readmissions, and mortality. We report statistics and temporal trends in GI endoscopy, cancers, and organ transplants. We estimated GI-specific health care expenditures and summarized National Institutes of Health (NIH) funding for GI research.